Title:
CRYSTALLINE COMPOSITE COMPRISING DAPAGLIFLOZIN AND METHOD FOR PREPARING SAME
Document Type and Number:
WIPO Patent Application WO/2016/018024
Kind Code:
A1
Abstract:
The present invention relates to a crystalline composite comprising dapagliflozin and a method for preparing the same. More specifically, the present invention provides a novel crystalline composite comprising dapagliflozin, which is an SGLT2 inhibitor, and a preparing method capable of economically preparing the novel crystalline composite at high purity.
More Like This:
| WO/2019/183159 | SAPONIN-BASED VACCINE ADJUVANTS |
Inventors:
KIM KI LIM (KR)
PARK CHULHYUN (KR)
LEE JAEHEON (KR)
CHANG YOUNG-KIL (KR)
PARK CHULHYUN (KR)
LEE JAEHEON (KR)
CHANG YOUNG-KIL (KR)
Application Number:
PCT/KR2015/007821
Publication Date:
February 04, 2016
Filing Date:
July 27, 2015
Export Citation:
Assignee:
HANMI FINE CHEMICAL CO LTD (KR)
International Classes:
C07H15/20; A61K31/70; A61P3/10
Domestic Patent References:
| WO2013079501A1 | 2013-06-06 |
Foreign References:
| US20080287529A1 | 2008-11-20 | |||
| KR20090023643A | 2009-03-05 | |||
| KR20090123964A | 2009-12-02 | |||
| US20130237487A1 | 2013-09-12 |
Attorney, Agent or Firm:
FIRSTLAW P.C. (KR)
제일특허법인 (KR)
제일특허법인 (KR)
Download PDF: